<DOC>
	<DOCNO>NCT01431781</DOCNO>
	<brief_summary>Pancreatitis one common complication post-ERCP ( Endoscopic Retrograde Cholangiopancreatography ) , incidence rate 5 &amp; -10 % , prevent PEP hyperamylasemia important issue , somatostatin widely use field pancreas treatment . In order explore effect somatostatin prevent PEP ( post-ERCP Pancreatitis ) , 908 subject enrol two group study , one group give common treatment , use somatostatin base common treatment .</brief_summary>
	<brief_title>The Prophylactic Effect Stilamin Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis</brief_title>
	<detailed_description>A prospective , multi-center , investigator sponsor , randomize control trial , 15 site join China , 908 subject enrol . A descriptive analysis perform primary endpoint , contain frequency number percentage patient . A two proportion equality test conduct explore whether incidence rate different . Descriptive statistic include number ( N ) , mean , median , standard deviation , minimum maximum , produce continuous variable . Frequency table number ( N ) percentage subject produce categorical variable .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Males female , age &gt; 18 year . Normal amylase level undergo ERCP . Signed inform consent form agree followup time . Pregnancy history allergy somatostatin . Renal insufficiency ( Scr &gt; 177umol/L ) . Acute myocardial infarction within 3 month procedure . History subtotal gastrectomy ( Billroth II Method ) . Symptom shock undergo ERCP , hypotension ( systolic blood pressure &lt; 90mmHg ) tachycardia ( HR &gt; 120 bpm ) . Medical psychological condition would permit patient complete study sign inform consent . Patients involve study within 60 day . Patients unfitted study investigator . All contraindication Stilamin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>